As biosimilar competition expands across TNF inhibitors, anti-VEGF biologics, and oncology supportive care, Cordavis-format co-branded private label products could generate incremental PBM segment revenue of $500 million to $1.5 billion annually by 2027, partly offsetting regulatory headwinds
To the best of our knowledge, this is the first work where such a broad ensemble of GHRPs was systematically studied by ECD and the achieved results document that this approach provides a suitable analytical tool not only for a description of their natural conformational preferences, but can also bring insight into their possible interactions with the surrounding environment
Beyond potential effects on motility, tirzepatide indirectly contributes to constipation through its appetite-suppressing effects
Author contributions SL: Conceptualization, Data curation, Formal Analysis, Investigation, Validation, Writing original draft, Writing review and editing
This leads to eating less, reducing overall calorie intake
